Company intelligence / Profile preview

Hologram Sciences

Boston, Massachusetts, United States

Ownership: Private
Employees: ~64
Development stage: Commercial

Overview

Hologram Sciences has launched commercial products that use AI for personalized nutrition advice. Its NuMLM platform is being piloted at Mayo Clinic for real-time nutritional monitoring to address malnutrition in surgical recovery patients. No traditional clinical trial results as with pharmaceuticals.

Therapeutic areas: Metabolic DisordersOther
Modalities: Device (digital diagnostics)Non-pharmacological therapy (personalized nutrition plans)Nutritional supplement
Industry: Food & Nutrition

Partnerships

Mayo Clinic (clinical pilot of NuMLM platform)Royal DSM/dsm-firmenich partnerships for ingredient supply and innovation support

Beyond the preview

Go deeper on Hologram Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hologram Sciences.

Explore the full profile